BioResearch Group has just started recruitment process for new study with hormone drug - testosterone:

Multicenter, Phase I, randomized, open-label, parallel group, single dose, single period, two-stage design trialto demonstrate bioequivalence of a 1000 mg testosterone undecanoate solution for intramuscular injection

The study is dedicated to healthy Volunteers or Patients with testosterone deficiency.

More information can be found on our dedicated for recruitmant website: www.udzialwbadaniu.pl.